UBS Group’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $216K | Buy |
27,501
+26,059
| +1,807% | +$270K | ﹤0.01% | 6596 |
|
|
2025
Q4 | $17K | Buy |
1,442
+1,425
| +8,382% | +$12.3K | ﹤0.01% | 7899 |
|
|
2025
Q3 | $137 | Buy |
+17
| New | +$118 | ﹤0.01% | 9874 |
|
|
2025
Q2 | – | Sell |
-724
| Closed | -$5.29K | – | 10194 |
|
|
2025
Q1 | $5.11K | Buy |
+724
| New | +$7.83K | ﹤0.01% | 9031 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 9861 |
|
|
2024
Q3 | – | Sell |
-57
| Closed | -$910 | – | 9918 |
|
|
2024
Q2 | $910 | Buy |
+57
| New | +$1.4K | ﹤0.01% | 8739 |
|
|
2024
Q1 | – | Sell |
-53
| Closed | -$1.07K | – | 9839 |
|
|
2023
Q4 | $1.07K | Buy |
+53
| New | +$732 | ﹤0.01% | 8413 |
|
|
2023
Q1 | – | Sell |
-88
| Closed | -$2.43K | – | 10163 |
|
|
2022
Q4 | $2.43K | Sell |
88
-504
| -85% | -$12.7K | ﹤0.01% | 9682 |
|
|
2022
Q3 | $15K | Buy |
+592
| New | +$23.3K | ﹤0.01% | 7819 |
|
|
2022
Q2 | – | Sell |
-69
| Closed | -$4K | – | 10753 |
|
|
2022
Q1 | $4K | Sell |
69
-987
| -93% | -$81.3K | ﹤0.01% | 9308 |
|
|
2021
Q4 | $134K | Buy |
1,056
+1,002
| +1,856% | +$164K | ﹤0.01% | 6028 |
|
|
2021
Q3 | $11K | Sell |
54
-331
| -86% | -$78.9K | ﹤0.01% | 7898 |
|
|
2021
Q2 | $102K | Sell |
385
-1,688
| -81% | -$522K | ﹤0.01% | 5861 |
|
|
2021
Q1 | $725K | Buy |
2,073
+1,977
| +2,059% | +$844K | ﹤0.01% | 4560 |
|
|
2020
Q4 | $49K | Buy |
+96
| New | +$38.4K | ﹤0.01% | 6204 |
|
|
2020
Q3 | – | Sell |
-231
| Closed | -$126K | – | 8301 |
|
|
2020
Q2 | $126K | Buy |
+231
| New | +$104K | ﹤0.01% | 5124 |
|
Other funds holding PASG
LCM
VPC
EP
VCM
YCM
IC
EAM
